New research conducted at Yale New Haven Health (YNHHS), and LifeBridge Health’s Sinai Hospital of Baltimore, has found that the Rothman Index score, a measure of patient acuity, helps identify COVID-19 patients at high risk of mortality.
Hear from experts as they discuss a recent 1,669 COVID-19 patient study across four hospitals in Connecticut and Maryland. The results demonstrated that the Rothman Index (RI) score, which can be calculated upon patient admission using the patient’s current health characteristics, accurately groups the majority of COVID-19 patients into high-risk (43% mortality rate) and low-risk (less than 5% mortality rate) categories.
DATE: Wednesday, October 14th
Time: 1:00 – 1:30 PM ET
Hospital executives, clinicians, and care managers who need to identify patients at risk of rapid decline, make decisions about transfer and discharge, predict the risk of severe infection, and improve the overall efficiency and quality of care.
The scientific article detailing the COVID patient analysis can be found in the following link: https://www.medrxiv.org/content/10.1101/2020.08.13.20171751v1